T1	Intervention 0 9	Pazopanib
T2	Intervention 116 125	Pazopanib
T3	Intervention 132 159	oral angiogenesis inhibitor
T4	Intervention 298 326	placebo-controlled phase III
T5	Intervention 366 387	pazopanib monotherapy
T6	Intervention 454 480	renal cell carcinoma (RCC)
T7	Intervention 613 638	oral pazopanib or placebo
T8	Intervention 934 949	treatment naive
T9	Intervention 969 988	cytokine pretreated
T10	Intervention 1033 1042	pazopanib
T11	Intervention 1057 1064	placebo
T12	Intervention 1191 1220	treatment-naive subpopulation
T13	Intervention 1304 1337	cytokine-pretreated subpopulation
T14	Intervention 1453 1462	pazopanib
T15	Intervention 1485 1492	placebo
T16	Intervention 1754 1778	pazopanib versus placebo
T17	Intervention 1878 1904	placebo in treatment-naive
T18	Intervention 1909 1937	cytokine-pretreated patients
T19	Intervention 1791 1800	Pazopanib
